Retinal Not Systemic Oxidative and Inflammatory Stress Correlated with VEGF Expression in Rodent Models of Insulin Resistance and Diabetes
Akira Mima(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Edward Yu(Joslin Diabetes Center), Jongsoon Lee(Soonchunhyang University), Junko Hiraoka-Yamomoto(Joslin Diabetes Center), Takeshi Shimada(Joslin Diabetes Center), Munehiro Kitada(Kanazawa Medical University), Christian Rask‐Madsen(University of Ulsan), Koji Mizutani(Nagoya University), Qian Li(Shanghai Jiao Tong University), Weier Qi(Joslin Diabetes Center), Christian Jobin(University of North Carolina at Chapel Hill), Kyoungmin Park(Joslin Diabetes Center), Motonobu Matsumoto(Joslin Diabetes Center), Steven E. Shoelson(Joslin Diabetes Center)
Cited by 54
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Crystal Structure of the Tyrosine Phosphatase SHP-2
|Cell|1998|1k